---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-008640"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:45:40.192188+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# CNS Pharmaceuticals holds virtual analyst and investor day; presentation content not detailed in filing excerpt

## Summary
- Virtual analyst and investor day held on December 11, 2024.
- Presentation furnished as Exhibit 99.1 was reviewed at the meeting.
- No financial results, guidance, or material updates disclosed in the provided exhibit excerpt.
- Filing under Item 7.01 Regulation FD; presentation not filed for Exchange Act purposes.

## SEC filing metadata
- accession: 0001683168-24-008640
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316824008640/0001683168-24-008640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824008640/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-008640
- JSON: https://secwatch.observer/filing/0001683168-24-008640.json
- Plain text: https://secwatch.observer/filing/0001683168-24-008640.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.